Splenic Artery Ligation and Portocaval Shunt in Small-for-size Syndrome
splen ligation
Hemodynamic Modulations to Ameliorate Sinusoidal Injuries After Extended Liver Resections: the Role of Splenic Artery Ligation and Porto-caval Shunt in a Series of Patients
1 other identifier
observational
13
1 country
1
Brief Summary
Our study aimed at assessing the changes of portal vein pressure, portal vein flow and hepatic arterial flow (HAF) in liver remnants ≤ 30% of the standard liver volume by reducing portal vein overflow via ligation of the splenic artery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jan 2017
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2021
CompletedFirst Submitted
Initial submission to the registry
July 10, 2022
CompletedFirst Posted
Study publicly available on registry
July 15, 2022
CompletedJuly 15, 2022
July 1, 2022
5 years
July 10, 2022
July 12, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
portal vein pressure
change of portal vein pressure from before liver resection to after reperfusion of the liver remnant
through the operation, an average period of two hours
portal vein flow
change of portal vein flow from before liver resection to after reperfusion of the liver remnant
through the operation, an average period of two hours
hepatic artery flow
change of hepatic artery flow from before liver resection to after reperfusion of the liver remnant
through the operation, an average period of two hours
Interventions
We identified portal hyperperfusion as a cause of potential small-for-size liver remnant dysfunction and we applied splenic artery ligation as a technically simple procedure to manage the situation
Eligibility Criteria
retrospective analysis of an internal hepatectomy database
You may qualify if:
- Adult patients
- American Society of Anesthesiologists (ASA) distribution I to III
- Patients scheduled for major liver resection (≥4 segments)
You may not qualify if:
- patients with extrahepatic disease
- patients with metastatic liver tumors
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Aretaieion University Hospital
Athens, Attica, 11528, Greece
Related Publications (5)
Theodoraki K, Arkadopoulos N, Nastos C, Vassiliou I, Karmaniolou I, Smyrniotis V. Small liver remnants are more vulnerable to ischemia/reperfusion injury after extended hepatectomies: a case-control study. World J Surg. 2012 Dec;36(12):2895-900. doi: 10.1007/s00268-012-1779-6.
PMID: 22956015BACKGROUNDGarcia-Valdecasas JC, Fuster J, Charco R, Bombuy E, Fondevila C, Ferrer J, Ayuso C, Taura P. Changes in portal vein flow after adult living-donor liver transplantation: does it influence postoperative liver function? Liver Transpl. 2003 Jun;9(6):564-9. doi: 10.1053/jlts.2003.50069.
PMID: 12783396BACKGROUNDKinaci E, Kayaalp C. Portosystemic Shunts for "Too Small-for-Size Syndrome" After Liver Transplantation: A Systematic Review. World J Surg. 2016 Aug;40(8):1932-40. doi: 10.1007/s00268-016-3518-x.
PMID: 27160453BACKGROUNDLo CM, Liu CL, Fan ST. Portal hyperperfusion injury as the cause of primary nonfunction in a small-for-size liver graft-successful treatment with splenic artery ligation. Liver Transpl. 2003 Jun;9(6):626-8. doi: 10.1053/jlts.2003.50081.
PMID: 12783407BACKGROUNDUmeda Y, Yagi T, Sadamori H, Matsukawa H, Matsuda H, Shinoura S, Mizuno K, Yoshida R, Iwamoto T, Satoh D, Tanaka N. Effects of prophylactic splenic artery modulation on portal overperfusion and liver regeneration in small-for-size graft. Transplantation. 2008 Sep 15;86(5):673-80. doi: 10.1097/TP.0b013e318181e02d.
PMID: 18791439BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kassiani Theodoraki
Aretaieion University Hospital, Athens, Greece
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Anesthesiology
Study Record Dates
First Submitted
July 10, 2022
First Posted
July 15, 2022
Study Start
January 1, 2017
Primary Completion
December 31, 2021
Study Completion
December 31, 2021
Last Updated
July 15, 2022
Record last verified: 2022-07
Data Sharing
- IPD Sharing
- Will not share